Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
In addition to being used as a recreational drug, marijuana has been used for centuries to treat a variety of conditions, from chronic pain to epilepsy. However, its medical value is greatly limited by debilitating side effects. A study published by Cell Press in the journal Cell has revealed the molecular pathways responsible for marijuana-induced learning and memory problems. The findings suggest that preventing these side effects could be as easy as taking an over-the-counter painkiller.
"Our studies have solved the longtime mystery of how marijuana causes neuronal and memory impairments," says senior study author Chu Chen of Louisiana State University Health Sciences Center. "The results suggest that the use of medical marijuana could be broadened if patients concurrently take a nonsteroidal anti-inflammatory drug such as ibuprofen."
The main active ingredient in marijuana is Delta9-tetrahydrocannabinol (Delta9-THC), and drugs based on this compound have been approved by the Food and Drug Administration (FDA) to treat nausea and vomiting in chemotherapy patients. But these drugs have not been approved for a wider range of conditions, in part because of Delta9-THC-induced side effects. Moreover, there are no effective FDA-approved treatments for these side effects because, until now, little was known about the molecular pathways underlying these impairments.
In the new study, Chen and his team discovered that Delta9-THC treatment caused an increase in levels of an enzyme called cyclooxygenase-2 (COX-2) in the mouse hippocampus, a brain region involved in learning and memory. Drugs or genetic techniques that reduced COX-2 levels in mice prevented memory problems and neuronal abnormalities caused by repeated Delta9-THC exposure. Because COX-2 is inhibited by over-the-counter painkillers such as ibuprofen, the findings suggest an easy strategy to prevent the side effects of marijuana.
The researchers also discovered that Delta9-THC treatment reduced neuronal damage in a mouse model of Alzheimer's disease, and this beneficial effect persisted when the animals were simultaneously treated with a COX-2 inhibitor. "There are no effective medications currently available for preventing and treating Alzheimer's disease or halting disease progression," Chen says. "Our results suggest that the unwanted side effects of cannabis could be eliminated or reduced, while retaining its beneficial effects, by administering a COX-2 inhibitor along with Delta9-THC for the treatment of intractable medical conditions such as Alzheimer's disease."
Cell, Chen et al.: "Δ9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling"
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Alcohol / Addiction / Illegal Drugs category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Press, Cell. "Ibuprofen may prevent marijuana-induced memory problems." Medical News Today. MediLexicon, Intl., 25 Nov. 2013. Web.
7 Mar. 2014. <http://www.medicalnewstoday.com/releases/269218>
Press, C. (2013, November 25). "Ibuprofen may prevent marijuana-induced memory problems." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/269218.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.